Generic Paxil Flap Ends Without Explanation

Litigation over generic Paxil sales ended Tuesday, when the embroiled drugmakers quietly agreed to drop the New Jersey federal suit accusing GlaxoSmithKline LLC of breaching an exclusivity agreement with Mylan by...

Already a subscriber? Click here to view full article